Author: Muñoz Alberto Barceló Ramón Viteri Ainhoa Rubio Itziar De Argumedo Gonzalo López López-Vivanco Guillermo
Publisher: Informa Healthcare
ISSN: 0284-186X
Source: Acta Oncologica, Vol.45, Iss.5, 2006-07, pp. : 621-622
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Severe Anaphylactic Reactions to Oxaliplatin
By Tournigand C. Maindrault-Goebel F. Louvet C. de Gramont A. Krulik M.
European Journal of Cancer, Vol. 34, Iss. 8, 1998-07 ,pp. :
The cellular pharmacology of oxaliplatin resistance
By Mishima M. Samimi G. Kondo A. Lin X. Howell S.B.
European Journal of Cancer, Vol. 38, Iss. 10, 2002-07 ,pp. :
Pharmacokinetics of heated intraperitoneal oxaliplatin
By Ferron G.
Cancer Chemotherapy and Pharmacology, Vol. 62, Iss. 4, 2008-09 ,pp. :
Pharmacokinetics of oxaliplatin in humans
By Ehrsson H. Wallin I. Yachnin J.
Medical Oncology, Vol. 19, Iss. 4, 2002-12 ,pp. :
Trastuzumab: unusual responses and toxicities
By Ahamed Eliyaz Mauri Francesco A Pakter Grant Lim Adrian Stebbing Justin
Future Oncology, Vol. 5, Iss. 6, 2009-08 ,pp. :